A phase I/<scp>II</scp> study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
- DOI
- 10.1002/ijc.34144
- Published
- 2022-06-21
- Container
- International Journal of Cancer
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/ijc.34144,
title = {A phase I/<scp>II</scp> study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma},
author = {Jung Hyun Jo and Dawoon E. Jung and Hee Seung Lee and Soo Been Park and Moon Jae Chung and Jeong Youp Park and Seungmin Bang and Seung Woo Park and Sangsook Cho and Si Young Song},
year = {2022},
journal = {International Journal of Cancer},
doi = {10.1002/ijc.34144},
url = {https://doi.org/10.1002/ijc.34144}
}RIS
TY - JOUR TI - A phase I/<scp>II</scp> study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma AU - Jung Hyun Jo AU - Dawoon E. Jung AU - Hee Seung Lee AU - Soo Been Park AU - Moon Jae Chung AU - Jeong Youp Park AU - Seungmin Bang AU - Seung Woo Park AU - Sangsook Cho AU - Si Young Song PY - 2022 JO - International Journal of Cancer DO - 10.1002/ijc.34144 UR - https://doi.org/10.1002/ijc.34144 ER -
APA
Jo, J. H., Jung, D. E., Lee, H. S., Park, S. B., Chung, M. J., Park, J. Y., Bang, S., Park, S. W., Cho, S., & Song, S. Y. (2022). A phase I/<scp>II</scp> study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma. International Journal of Cancer. https://doi.org/10.1002/ijc.34144
Source records
- crossref · retrieved 2026-09-26T16:46:34.928Z